Generic Injectables Market Pegged For Robust Expansion By 2024


Generic Injectables Market Pegged for Robust Expansion by 2024

Several top players in the generic injectables market are focusing on mergers and acquisitions to consolidate their shares. They are also making substantial investment in research and development activities with an aim to develop new products, in order to gain an edge over their competitors, notes Transparency Market Research (TMR). Some of the companies holding leading positions in the market are Biocon Limited, Sanofi, Lupin Ltd., Hikma Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius SE & Co. KGaA, Baxter, Novartis AG (Sandoz International GmbH), and Pfizer Inc.A growing number of producers of generic injectables are focusing on products that meet the highest standard of efficacy and safety as that of the originator products.


Request a PDF Brochure -


The global generic injectables market is projected to expand rapidly from its worth of US$ 49.0 billion in 2016 to reach a worth of over US$ 150 billion by 2025. This represents a robust CAGR of nearly 13.6% during the forecast period of 2017–2025.


The various product types can be grouped into ampoules, vials, premixes, and prefilled syringes. Of all the segments, the market for prefilled syringes is expected to rise at the most attractive CAGR during the assessment period. The higher precision of dose, ease of self-administration, and reduced wastage of products are some of the compelling benefits accounting for their widespread acceptance.


Regionally, Asia Pacific led the global market in 2016 with substantial uptake of generic injectables among patient populations. The regional market is anticipated to rise at a rapid pace, attributed to the widespread demand for affordable therapeutics and sustained governmental thrust in key economies.


Request a Sample of Generic Injectables Market:


Demand for Affordable Quality Therapeutics propels Demand for Generic Injectable


The continued drive for generic injectable gains strength from the pressing need for quality therapeutics at affordable prices among patient populations world over, amid the soaring healthcare cost. The loss of patents for various blockbuster biological molecules in the years to come, coupled with the broadening acceptance of biologics, is a notable aspect propelling the demand for generic injectables. Spiraling spending on research and development of biologics is providing a large impetus to the growth of the market.


Broadening Acceptance of Prefilled Syringes as Advanced Drug Delivery System adds Sizeable Market Revenue


Efforts to bring constant innovation in drug delivery mechanism for injectables are catalyzing the demand for generic injectables. In this regard, the widespread acceptance of prefilled syringes among healthcare workers and patient populations at large is providing a robust impetus to the market’s growth. The number of attractive benefits drug delivery method has with the use of prefilled syringes has bolstered their uptake in parenteral drug delivery across the globe.


Furthermore, constant technological advances in drug delivery systems, especially in developed countries, is notably accentuating the growth of the market. Recent advances in the delivery mechanism of complex therapeutic molecules has imparted a noticeable momentum to the market’s growth.


Request for Analysis of COVID19 Impact on Generic Injectables Market -


Strict Regulatory Frameworks Hindering New Entrants, Oncology Biosimilars to open Promising Avenue


However, the market also suffers from certain setbacks. The high cost of investment required for setting manufacturing plants has constrained the entry of new players. Furthermore, a stringent regulatory framework with respect to large molecule generic injectables in developed countries, such as the U.S., is also hindering the market’s growth.


Nevertheless, the rapidly rising demand for lower-cost generic versions of vital medications among clinicians and patients will continue adding to the global revenues. A number of manufacturers or producers are putting their focus toward the area of oncology therapeutics. To this end, prominent players are making sizeable investment in R&D in oncology biosimilars to be delivered in injectable form. This will provide sustained fillip to the growth of the market over the forecast period.


Purchase Generic Injectables Market Report -


The study presented here is based on a report by Transparency Market Research (TMR) titled “Generic Injectables Market (Product Type - Large Molecule Injectables (Biosimilars), Small Molecule Injectables; Container Type - Vials, Ampoules, Premixes, and Prefilled Syringes; Application - Oncology, Infectious Diseases, Cardiology, Diabetes, and Immunology; Route of Administration - Intravenous, Intramuscular, and Subcutaneous) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025


More Trending Reports by Transparency Market Research:


About Us


Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.


Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.


TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”




Transparency Market Research


State Tower,


90 State Street,


Suite 700,


Albany NY - 12207


United States


USA - Canada Toll Free: 866-552-3453




Keywords: generic injectables market


Other related blogs

Symptoms of fissures

By : Vedas Cure

Butt-centric Symptoms of fissures Therapeutically Reviewed by Neha Pathak, MD on October 19, 2..

Treatment of fissures

By : Vedas Cure

Treatment for Anal Fissures Medicinally Reviewed by Nayana Ambardekar, MD on June 28, 2020 IN THIS..

Symptoms of fistula

By : Vedas Cure

Butt-centric Fistula Symptoms or Symptoms of fistula Download PDF Copy Yolanda Smith, B.Pharm..

Treatment of fistula

By : Vedas Cure

Butt-centric Treatment of fistula Yolanda Smith, B.Pharm. By Yolanda Smith, B.Pharm. Assesse..